Quantification of PPAR-gamma protein in monocyte/macrophages from healthy smokers and non-smokers: a possible direct effect of nicotine
- PMID: 17765929
- DOI: 10.1016/j.lfs.2007.07.017
Quantification of PPAR-gamma protein in monocyte/macrophages from healthy smokers and non-smokers: a possible direct effect of nicotine
Abstract
Previous observations demonstrated that Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma), a key regulator of adipocyte differentiation, is expressed in a large variety of cells, including cells of the monocyte/macrophage lineage. This study was aimed to quantify both the constitutive and ligand-induced PPAR-gamma expression in monocytes and monocyte-derived macrophages (MDM) isolated from healthy smokers and non-smokers, and to evaluate the possible direct effect of nicotine. PPAR-gamma protein was detected by Western blot and quantification was performed by calculating the ratio between PPAR-gamma and beta-actin protein expression. Cytokine release was measured with enzyme-linked immunoassay kits. Constitutive PPAR-gamma protein was detected in human monocytes and its expression was up-regulated along with differentiation to MDM. The endogenous ligand 15-deoxy-delta(12,14)-prostaglandin J(2) and the synthetic agonist ciglitazone enhanced PPAR-gamma expression, the former being effective also at low micromolar concentrations. Both agonists significantly inhibited the basal secretion of pro-inflammatory cytokines (e.g., TNF-alpha, IL-6), ciglitazone being more potent. Monocytes and MDM from healthy smokers presented a significantly enhanced (4-fold and 2.5-fold, respectively) constitutive PPAR-gamma expression, as compared to those from healthy non-smokers. However, ligand-induced PPAR-gamma expression and inhibition of cytokine secretion were similar in healthy smokers and non-smokers. Nicotine dose-dependently enhanced PPAR-gamma expression with a maximum at 10 muM, and inhibited release of pro-inflammatory cytokines; these effects were reversed by alpha-bungarotoxin. Nicotine and PPAR-gamma agonists did not exert synergistic effects. In conclusion, monocytes and MDM from healthy smokers present a constitutively enhanced PPAR-gamma expression; this effect is reproduced, to some extent, by nicotine in vitro.
Similar articles
-
A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages.Br J Pharmacol. 2008 May;154(1):144-52. doi: 10.1038/bjp.2008.50. Epub 2008 Feb 18. Br J Pharmacol. 2008. PMID: 18278062 Free PMC article.
-
The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages.Pharmacol Res. 2010 Nov;62(5):391-9. doi: 10.1016/j.phrs.2010.07.006. Epub 2010 Jul 27. Pharmacol Res. 2010. PMID: 20670683
-
Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages.Cardiovasc Res. 2012 Jun 1;94(3):537-44. doi: 10.1093/cvr/cvs125. Epub 2012 Mar 16. Cardiovasc Res. 2012. PMID: 22425902
-
Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.Bone. 2008 Apr;42(4):765-74. doi: 10.1016/j.bone.2007.11.016. Epub 2007 Dec 15. Bone. 2008. PMID: 18242157
-
Seasonal variation in the phagocytic activity and arachidonic-acid metabolism of human blood monocytes in healthy non-smokers, smokers and chronic bronchitics.Agents Actions Suppl. 1990;30:121-32. doi: 10.1007/978-3-0348-7488-5_9. Agents Actions Suppl. 1990. PMID: 2122656 Review.
Cited by
-
PPARγ upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats.Med Sci Monit. 2015 Jan 21;21:268-75. doi: 10.12659/MSM.891407. Med Sci Monit. 2015. PMID: 25619160 Free PMC article.
-
Influence of smoking on colonic gene expression profile in Crohn's disease.PLoS One. 2009 Jul 15;4(7):e6210. doi: 10.1371/journal.pone.0006210. PLoS One. 2009. PMID: 19603079 Free PMC article.
-
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?Parkinsons Dis. 2011;2011:689181. doi: 10.4061/2011/689181. Epub 2011 Mar 29. Parkinsons Dis. 2011. PMID: 21603186 Free PMC article.
-
Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence.Curr Drug Targets. 2013 Jun;14(7):768-76. doi: 10.2174/1389450111314070006. Curr Drug Targets. 2013. PMID: 23614675 Free PMC article. Review.
-
MUC1 in macrophage: contributions to cigarette smoke-induced lung cancer.Cancer Res. 2014 Jan 15;74(2):460-70. doi: 10.1158/0008-5472.CAN-13-1713. Epub 2013 Nov 26. Cancer Res. 2014. PMID: 24282280 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources